在帕金森病中用于纵向分层的综合网络方法
Barry Ryan1, Riccardo Marioni2, T Ian Simpson1
1School of Informatics, The University of Edinburgh, Edinburgh, United Kingdom.
PLoS computational biology
|March 28, 2025
概括
本研究使用多种数据探索帕金森病 (PD) 的进展. 整合临床,基因组和蛋白质组数据可以揭示不同疾病阶段的不同信息模式,有助于个性化诊断.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物标志物发现发现
背景情况:
- 帕金森病 (PD) 是一种异质的神经退行性疾病,没有治愈方法.
- 由于不同的触发因素和机制,了解纵向变性至关重要.
- 基因组数据提供了洞察力,但全面的理解需要整合多种数据类型.
研究的目的:
- 识别不同帕金森病阶段的信息数据模式及其组合.
- 验证灵活数据整合对于患者分层的重要性.
- 为了探索遗传性和异常性PD之间共享的分子信号.
主要方法:
- 临床,基因组和蛋白质组数据的纵向和横截面分析.
- 使用了来自帕金森病进展标记计划 (PPMI) 的数据.
- 研究了数据模式的组合,以在各种疾病阶段实现最佳分层.
主要成果:
- 证明不同数据模式的组合在不同PD阶段的分层是最佳的.
- 在患有PD引起基因突变和异常PD的参与者之间识别了共享的DNA甲基化 (DNAm) 签名.
- 展示了将单核酸多态 (SNP) 和DNAm集成为在遗传倾向的个体中早期诊断的潜力.
结论:
- 灵活的数据整合对于理解和管理帕金森病异质性至关重要.
- 共享的分子信号表明,遗传性和异常性PD的共同潜在机制.
- 结合SNP和DNAm分析显示,作为遗传性PD的早期诊断工具具有前途.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
